US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

47.19

-0.0150-0.03%

Volume:126.55K

Turnover:6.03M

Market Cap:7.92B

PE:121.54

High:48.73

Open:47.70

Low:47.01

Close:47.20

52wk High:55.67

52wk Low:25.17

Shares:167.76M

Float Shares:155.00M

Volume Ratio:0.35

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3882

EPS(LYR):1.43

ROE:3.85%

ROA:4.20%

PB:4.38

PE(LYR):33.00

Loading ...

Overview Company News Filings

Movement Alert｜Alkermes Rises 6.97% in Regular Trading, Narcolepsy Drug Phase 2 Trial Meets Dual Primary Endpoints and Advances to Phase 3

Alkermes price target raised to $61 from $54 at Needham

Alkermes is Maintained at Buy by Needham

Analysts Offer Insights on Healthcare Companies: McKesson (MCK) and Alkermes (ALKS)

Alkermes Plc : Needham Raises Target Price to $61 from $54

THOMSON REUTERS

Alkermes Plc : Deutsche Bank Raises Target Price to $60 From $47

THOMSON REUTERS

Alkermes Plc : Needham Raises Target Price to $54 From $50

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Alkermes (ALKS) and Connect Biopharma Holdings (CNTB)

Alkermes data support alixorexton in narcolepsy type 2, says H.C. Wainwright

Alkermes Is Maintained at Buy by Needham

Targeting the Brain's 'Wake Switch': Alkermes's Narcolepsy Drug Shows Promising Mid-Stage Data, Igniting Race in Orexin Pathway

Alkermes' Phase 2 Trial of Alixorexton to Treat Narcolepsy Meets Dual Primary Endpoints

MT Newswires Live

Alkermes presents positive results from Phase 2 study of Alixorexton

Alkermes says phase 2 Vibrance-2 trial shows alixorexton improves wakefulness in narcolepsy type 2

Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at Sleep 2026

THOMSON REUTERS

Alkermes (ALKS) Receives a Buy from Piper Sandler

Alkermes' Sleep Disorder Drug Receives Orphan Drug Status in US and Europe

MT Newswires Live

Alkermes says alixorexton enters phase 3 Brilliance trials for narcolepsy type 1, type 2

Alkermes says FDA grants orphan drug designation for alixorexton in idiopathic hypersomnia

Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/ALKS/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALKS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALKS\",,,,,undefined,":{"symbol":"ALKS","market":"US","secType":"STK","nameCN":"Alkermes PLC","latestPrice":47.185,"timestamp":1788361909419,"preClose":47.2,"halted":0,"volume":126551,"delay":0,"changeRate":-0.00031779661016950354,"floatShares":155000000,"shares":167763272,"eps":0.388236,"marketStatus":"Trading","change":-0.015,"latestTime":"09-02 11:11:50 EDT","open":47.7,"high":48.725,"low":47.01,"amount":6030628.956944,"amplitude":0.036335,"askPrice":47.23,"askSize":151,"bidPrice":47.14,"bidSize":207,"shortable":3,"etf":0,"ttmEps":0.388236,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":47.2,"preHourTrading":{"tag":"盘前","latestPrice":47.76,"preClose":47.2,"latestTime":"09:28 EDT","volume":2107,"amount":99454.02404,"timestamp":1788355732073,"change":0.56,"changeRate":0.011864,"amplitude":0.022246},"postHourTrading":{"tag":"盘后","latestPrice":47.2,"preClose":47.2,"latestTime":"19:30 EDT","volume":193868,"amount":9150569.18,"timestamp":1788305400471,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.345538,"impliedVol":0.3632,"impliedVolPercentile":0.0952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALKS\",,,,,undefined,":{"symbol":"ALKS","floatShares":155000000,"roa":"4.20%","roe":"3.85%","lyrEps":1.43,"volumeRatio":0.345538,"shares":167763272,"dividePrice":0,"high":48.725,"amplitude":0.036335,"preClose":47.2,"low":47.01,"week52Low":25.165,"pbRate":"4.38","psRate":"4.75","week52High":55.67,"institutionHeld":0.9671,"latestPrice":47.185,"committee":0.156425,"eps":0.388236,"divideRate":0,"volume":126551,"delay":0,"ttmEps":0.388236,"open":47.7,"prevYearClose":27.98,"prevWeekClose":47.41,"prevMonthClose":46.99,"prevQuarterClose":52.395,"fiveDayClose":49.16,"twentyDayClose":49.61,"sixtyDayClose":42.45,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALKS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-28","symbol":"ALKS","fiscalQuarterEnding":"2026/06","expectedEps":-0.04,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785211200000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2026-05-05","symbol":"ALKS","fiscalQuarterEnding":"2026/03","expectedEps":-0.57,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2026-02-25","symbol":"ALKS","fiscalQuarterEnding":"2025/12","expectedEps":0.31,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"pre","actualEps":0.34},{"market":"US","date":"2026-01-12","symbol":"ALKS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"ALKS","fiscalQuarterEnding":"2025/09","expectedEps":0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALKS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALKS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2105,"buy":0.5263,"hold":0.2105,"sell":0.0526,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALKS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALKS","date":"2026-08-31","current":121.575537,"percent":0.981541,"low":-99.853332,"twenty":-40.55077,"median":13.388312,"eighty":18.83597,"high":128.125542,"avg":-4.643165,"sd":42.214404,"marketCap":7953656725},"quantilePoints":[{"date":"2021-09-03","current":-76.672915,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4817359246},{"date":"2021-09-10","current":-78.367628,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4923838051},{"date":"2021-09-17","current":-77.314852,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4857692127},{"date":"2021-09-24","current":-82.373313,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5175515225},{"date":"2021-10-01","current":-79.292017,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4981917399},{"date":"2021-10-08","current":-81.397569,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5114209247},{"date":"2021-10-15","current":-81.320536,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5109369301},{"date":"2021-10-22","current":-79.214984,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4977077453},{"date":"2021-10-29","current":-53.423232,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4898055566},{"date":"2021-11-05","current":-53.493781,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4904523781},{"date":"2021-11-12","current":-42.294127,"twenty":-50.154251,"median":-35.906358,"eighty":-20.409777,"marketCap":3877694700},{"date":"2021-11-19","current":-40.98897,"twenty":-49.694628,"median":-35.906358,"eighty":-20.409777,"marketCap":3758032729},{"date":"2021-11-26","current":-39.630902,"twenty":-49.492729,"median":-35.906358,"eighty":-20.409777,"marketCap":3633519596},{"date":"2021-12-03","current":-38.8725,"twenty":-49.409499,"median":-35.906358,"eighty":-20.409777,"marketCap":3563986288},{"date":"2021-12-10","current":-38.502118,"twenty":-49.260842,"median":-35.906358,"eighty":-20.409777,"marketCap":3530028161},{"date":"2021-12-17","current":-41.200617,"twenty":-48.983435,"median":-35.906358,"eighty":-20.409777,"marketCap":3777437373},{"date":"2021-12-23","current":-42.488136,"twenty":-48.911898,"median":-35.906358,"eighty":-20.409777,"marketCap":3895482291},{"date":"2021-12-31","current":-41.024245,"twenty":-48.71686,"median":-35.906358,"eighty":-20.409777,"marketCap":3761266836},{"date":"2022-01-07","current":-42.347038,"twenty":-48.396814,"median":-35.934227,"eighty":-20.409786,"marketCap":3882545861},{"date":"2022-01-14","current":-44.534057,"twenty":-48.237657,"median":-35.934227,"eighty":-20.409786,"marketCap":4083060516},{"date":"2022-01-21","current":-42.329401,"twenty":-48.134628,"median":-35.934227,"eighty":-20.409786,"marketCap":3880928808},{"date":"2022-01-28","current":-44.234224,"twenty":-47.856145,"median":-35.934227,"eighty":-20.409786,"marketCap":4055570604},{"date":"2022-02-04","current":-41.817921,"twenty":-47.644696,"median":-35.934227,"eighty":-20.409786,"marketCap":3834034251},{"date":"2022-02-11","current":-40.918421,"twenty":-47.524593,"median":-35.934227,"eighty":-20.409786,"marketCap":3751564514},{"date":"2022-02-18","current":-84.332018,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4062188990},{"date":"2022-02-25","current":-83.424138,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4018457290},{"date":"2022-03-04","current":-77.943229,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":3754447400},{"date":"2022-03-11","current":-81.978254,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":3948810510},{"date":"2022-03-18","current":-87.82904,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4230637018},{"date":"2022-03-25","current":-92.233942,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4442816746},{"date":"2022-04-01","current":-94.35233,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4544857379},{"date":"2022-04-08","current":-99.631487,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4799149114},{"date":"2022-04-14","current":-98.723607,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4755417414},{"date":"2022-04-22","current":-95.615075,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4605682543},{"date":"2022-04-29","current":-76.473016,"twenty":-47.524593,"median":-36.079146,"eighty":-20.409786,"marketCap":4714867305},{"date":"2022-05-06","current":-73.239148,"twenty":-47.644696,"median":-36.311039,"eighty":-20.409786,"marketCap":4515486435},{"date":"2022-05-13","current":-71.251115,"twenty":-47.856145,"median":-36.514549,"eighty":-20.409786,"marketCap":4392916227},{"date":"2022-05-20","current":-79.521333,"twenty":-48.134628,"median":-36.669968,"eighty":-20.409786,"marketCap":4902808290},{"date":"2022-05-27","current":-80.952717,"twenty":-48.282786,"median":-36.809313,"eighty":-20.409786,"marketCap":4991058839},{"date":"2022-06-03","current":-77.692343,"twenty":-48.396814,"median":-36.895372,"eighty":-20.409786,"marketCap":4790043699},{"date":"2022-06-10","current":-73.104657,"twenty":-48.753891,"median":-37.077955,"eighty":-20.409786,"marketCap":4507194550},{"date":"2022-06-17","current":-74.622125,"twenty":-48.950091,"median":-37.212055,"eighty":-20.409786,"marketCap":4600752485},{"date":"2022-06-24","current":-79.09466,"twenty":-49.022902,"median":-37.321505,"eighty":-20.409777,"marketCap":4876502188},{"date":"2022-07-01","current":-81.277684,"twenty":-49.282838,"median":-37.389331,"eighty":-20.409777,"marketCap":5011094305},{"date":"2022-07-08","current":-84.791819,"twenty":-49.409499,"median":-37.46584,"eighty":-20.409777,"marketCap":5227754786},{"date":"2022-07-15","current":-79.68035,"twenty":-49.492729,"median":-37.601025,"eighty":-20.409777,"marketCap":4912612269},{"date":"2022-07-22","current":-76.725281,"twenty":-49.769136,"median":-37.711507,"eighty":-20.409777,"marketCap":4730420500},{"date":"2022-07-29","current":-44.659913,"twenty":-50.043112,"median":-37.815476,"eighty":-20.409777,"marketCap":4204909440},{"date":"2022-08-05","current":-44.956483,"twenty":-50.043112,"median":-37.914647,"eighty":-20.409777,"marketCap":4232832666},{"date":"2022-08-12","current":-45.619403,"twenty":-50.043112,"median":-38.002104,"eighty":-20.409777,"marketCap":4295249291},{"date":"2022-08-19","current":-44.066773,"twenty":-50.043112,"median":-38.10506,"eighty":-20.409777,"marketCap":4149062986},{"date":"2022-08-26","current":-42.810713,"twenty":-50.043112,"median":-38.291941,"eighty":-20.409777,"marketCap":4030799908},{"date":"2022-09-02","current":-42.758378,"twenty":-50.043112,"median":-38.448007,"eighty":-20.409777,"marketCap":4025872280},{"date":"2022-09-09","current":-41.886114,"twenty":-50.043112,"median":-38.5362,"eighty":-20.409777,"marketCap":3943745142},{"date":"2022-09-16","current":-40.769616,"twenty":-50.043112,"median":-38.660853,"eighty":-20.409777,"marketCap":3838622406},{"date":"2022-09-23","current":-38.937862,"twenty":-50.043112,"median":-38.765906,"eighty":-20.409777,"marketCap":3666155418},{"date":"2022-09-30","current":-38.955307,"twenty":-50.043112,"median":-38.937862,"eighty":-20.409777,"marketCap":3667797960},{"date":"2022-10-07","current":-38.606401,"twenty":-50.043112,"median":-39.109838,"eighty":-20.409777,"marketCap":3634947105},{"date":"2022-10-14","current":-39.46122,"twenty":-50.043112,"median":-39.133049,"eighty":-20.409777,"marketCap":3715431700},{"date":"2022-10-21","current":-38.83319,"twenty":-50.043112,"median":-39.135862,"eighty":-20.409777,"marketCap":3656300161},{"date":"2022-10-28","current":-40.699835,"twenty":-50.043112,"median":-39.199541,"eighty":-20.409777,"marketCap":3832052235},{"date":"2022-11-04","current":-30.511153,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3940210296},{"date":"2022-11-11","current":-30.014933,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3876128478},{"date":"2022-11-18","current":-29.824079,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3851481624},{"date":"2022-11-25","current":-30.791072,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3976359015},{"date":"2022-12-02","current":-33.195829,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4286909368},{"date":"2022-12-09","current":-31.427251,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4058515193},{"date":"2022-12-16","current":-32.470585,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4193251325},{"date":"2022-12-23","current":-32.432414,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4188321954},{"date":"2022-12-30","current":-33.246723,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4293481862},{"date":"2023-01-06","current":-34.493635,"twenty":-49.769136,"median":-39.154696,"eighty":-20.409777,"marketCap":4454507971},{"date":"2023-01-13","current":-34.748106,"twenty":-49.492729,"median":-39.12976,"eighty":-20.409777,"marketCap":4487370442},{"date":"2023-01-20","current":-35.269773,"twenty":-49.420616,"median":-39.023312,"eighty":-20.409777,"marketCap":4554738508},{"date":"2023-01-27","current":-36.923839,"twenty":-49.282838,"median":-38.850635,"eighty":-20.409777,"marketCap":4768344571},{"date":"2023-02-03","current":-34.799001,"twenty":-48.983435,"median":-38.742102,"eighty":-20.409777,"marketCap":4493942936},{"date":"2023-02-10","current":-34.468187,"twenty":-48.9133,"median":-38.606401,"eighty":-20.409777,"marketCap":4451221724},{"date":"2023-02-17","current":-29.155811,"twenty":-48.645431,"median":-38.5362,"eighty":-20.409777,"marketCap":4614402682},{"date":"2023-02-24","current":-28.231383,"twenty":-48.351507,"median":-38.448007,"eighty":-20.409777,"marketCap":4468096363},{"date":"2023-03-03","current":-28.304091,"twenty":-48.220837,"median":-38.373879,"eighty":-20.409777,"marketCap":4479603601},{"date":"2023-03-10","current":-27.639335,"twenty":-48.116754,"median":-38.274941,"eighty":-20.409777,"marketCap":4374394563},{"date":"2023-03-17","current":-27.036899,"twenty":-47.811464,"median":-38.093155,"eighty":-20.409777,"marketCap":4279048871},{"date":"2023-03-24","current":-27.514693,"twenty":-47.598057,"median":-37.993052,"eighty":-20.409777,"marketCap":4354667868},{"date":"2023-03-31","current":-29.280453,"twenty":-47.463781,"median":-37.913785,"eighty":-20.409786,"marketCap":4634129377},{"date":"2023-04-06","current":-30.506098,"twenty":-47.463781,"median":-37.82284,"eighty":-20.409786,"marketCap":4828108542},{"date":"2023-04-14","current":-31.035826,"twenty":-47.475869,"median":-37.711507,"eighty":-20.409777,"marketCap":4911946995},{"date":"2023-04-21","current":-30.121785,"twenty":-47.475869,"median":-37.601025,"eighty":-20.409777,"marketCap":4767284567},{"date":"2023-04-28","current":-28.670049,"twenty":-47.475869,"median":-37.46584,"eighty":-20.409777,"marketCap":4707880022},{"date":"2023-05-05","current":-29.044358,"twenty":-47.475869,"median":-37.38821,"eighty":-20.409777,"marketCap":4769344934},{"date":"2023-05-12","current":-31.543123,"twenty":-47.378573,"median":-37.313027,"eighty":-20.409777,"marketCap":5179664753},{"date":"2023-05-19","current":-30.531477,"twenty":-47.214893,"median":-37.152993,"eighty":-20.409777,"marketCap":5013543369},{"date":"2023-05-26","current":-29.722161,"twenty":-47.214893,"median":-36.987674,"eighty":-20.409777,"marketCap":4880646261},{"date":"2023-06-02","current":-29.620996,"twenty":-47.130816,"median":-36.919193,"eighty":-20.409767,"marketCap":4864034123},{"date":"2023-06-09","current":-31.907316,"twenty":-46.901522,"median":-36.809313,"eighty":-20.409767,"marketCap":5239468451},{"date":"2023-06-16","current":-32.301858,"twenty":-46.574329,"median":-36.669968,"eighty":-20.409767,"marketCap":5304255791},{"date":"2023-06-23","current":-34.021656,"twenty":-46.462045,"median":-36.564066,"eighty":-20.409758,"marketCap":5586662143},{"date":"2023-06-30","current":-31.69487,"twenty":-46.464564,"median":-36.443843,"eighty":-20.409749,"marketCap":5204582960},{"date":"2023-07-07","current":-30.399963,"twenty":-46.464564,"median":-36.324905,"eighty":-20.409749,"marketCap":4991947589},{"date":"2023-07-14","current":-30.359498,"twenty":-46.464564,"median":-36.212917,"eighty":-20.409749,"marketCap":4985302733},{"date":"2023-07-21","current":-32.342324,"twenty":-46.464564,"median":-35.934227,"eighty":-20.409749,"marketCap":5310900646},{"date":"2023-07-28","current":48.950981,"twenty":-46.442933,"median":-35.452039,"eighty":-20.368741,"marketCap":5041559440},{"date":"2023-08-04","current":44.683255,"twenty":-46.317214,"median":-35.211157,"eighty":-20.301088,"marketCap":4602017848},{"date":"2023-08-11","current":44.87732,"twenty":-45.967039,"median":-35.023652,"eighty":-20.120159,"marketCap":4622004896},{"date":"2023-08-18","current":46.446004,"twenty":-45.664437,"median":-34.69182,"eighty":-19.956848,"marketCap":4783566869},{"date":"2023-08-25","current":44.570051,"twenty":-45.404618,"median":-34.474549,"eighty":-19.830023,"marketCap":4590358736},{"date":"2023-09-01","current":47.206089,"twenty":-44.974989,"median":-34.130848,"eighty":-19.651548,"marketCap":4861849474},{"date":"2023-09-08","current":47.206089,"twenty":-44.907093,"median":-33.585511,"eighty":-19.51296,"marketCap":4861849474},{"date":"2023-09-15","current":48.273441,"twenty":-44.907093,"median":-33.253085,"eighty":-19.271435,"marketCap":4971778239},{"date":"2023-09-22","current":48.047033,"twenty":-44.802128,"median":-33.04036,"eighty":-19.191423,"marketCap":4948460016},{"date":"2023-09-29","current":45.540372,"twenty":-44.659913,"median":-32.766368,"eighty":-19.065691,"marketCap":4690293977},{"date":"2023-10-06","current":45.993188,"twenty":-44.528541,"median":-32.483308,"eighty":-18.951388,"marketCap":4736930423},{"date":"2023-10-13","current":44.262783,"twenty":-44.236515,"median":-32.381007,"eighty":-18.699922,"marketCap":4558712576},{"date":"2023-10-20","current":43.357151,"twenty":-44.110763,"median":-32.257067,"eighty":-18.558361,"marketCap":4465439685},{"date":"2023-10-27","current":19.196586,"twenty":-44.052817,"median":-32.165219,"eighty":-18.485448,"marketCap":4121967764},{"date":"2023-11-03","current":19.080008,"twenty":-43.835622,"median":-32.114324,"eighty":-18.329394,"marketCap":4096935571},{"date":"2023-11-10","current":19.04892,"twenty":-43.835622,"median":-31.907316,"eighty":-18.128571,"marketCap":4090260319},{"date":"2023-11-17","current":18.162924,"twenty":-43.835622,"median":-31.735336,"eighty":-17.870084,"marketCap":3900015653},{"date":"2023-11-24","current":18.955657,"twenty":-43.835622,"median":-31.583589,"eighty":-17.644018,"marketCap":4070234565},{"date":"2023-12-01","current":18.76136,"twenty":-43.835622,"median":-31.427251,"eighty":-17.293018,"marketCap":4028514244},{"date":"2023-12-08","current":20.331283,"twenty":-43.821513,"median":-31.320561,"eighty":-17.111515,"marketCap":4365614441},{"date":"2023-12-15","current":20.945263,"twenty":-43.821513,"median":-30.985981,"eighty":-16.974211,"marketCap":4497450657},{"date":"2023-12-22","current":21.411577,"twenty":-43.821513,"median":-30.840029,"eighty":-16.775651,"marketCap":4597579429},{"date":"2023-12-29","current":21.668049,"twenty":-43.835622,"median":-30.75404,"eighty":-16.674022,"marketCap":4652650253},{"date":"2024-01-05","current":22.250942,"twenty":-43.849732,"median":-30.587118,"eighty":-16.545483,"marketCap":4777811218},{"date":"2024-01-12","current":21.714681,"twenty":-43.849732,"median":-30.537472,"eighty":-16.468673,"marketCap":4662663130},{"date":"2024-01-19","current":21.574787,"twenty":-43.863842,"median":-30.498429,"eighty":-16.419138,"marketCap":4632624499},{"date":"2024-01-26","current":21.776856,"twenty":-43.849732,"median":-30.390709,"eighty":-16.359531,"marketCap":4676013633},{"date":"2024-02-02","current":20.937491,"twenty":-43.849732,"median":-30.268366,"eighty":-16.245798,"marketCap":4495781844},{"date":"2024-02-09","current":20.805369,"twenty":-43.849732,"median":-30.124302,"eighty":-16.099824,"marketCap":4467412026},{"date":"2024-02-16","current":15.282535,"twenty":-43.849732,"median":-30.000061,"eighty":-15.989003,"marketCap":5436868800},{"date":"2024-02-23","current":13.569352,"twenty":-43.849732,"median":-29.813586,"eighty":-15.868185,"marketCap":4827391800},{"date":"2024-03-01","current":13.943479,"twenty":-43.835622,"median":-29.691811,"eighty":-15.810302,"marketCap":4960490388},{"date":"2024-03-08","current":13.830767,"twenty":-43.835622,"median":-29.445673,"eighty":-15.761184,"marketCap":4920392116},{"date":"2024-03-15","current":13.563075,"twenty":-43.835622,"median":-29.155811,"eighty":-15.689068,"marketCap":4825158721},{"date":"2024-03-22","current":12.666071,"twenty":-43.835622,"median":-28.997047,"eighty":-15.65825,"marketCap":4506043307},{"date":"2024-03-28","current":12.797569,"twenty":-43.835622,"median":-28.957305,"eighty":-15.60417,"marketCap":4552824624},{"date":"2024-04-05","current":12.121293,"twenty":-43.849732,"median":-28.827848,"eighty":-15.449766,"marketCap":4312234992},{"date":"2024-04-12","current":11.884271,"twenty":-43.849732,"median":-28.713822,"eighty":-15.310254,"marketCap":4227912733},{"date":"2024-04-19","current":11.299331,"twenty":-43.849732,"median":-28.508069,"eighty":-15.24785,"marketCap":4019816188},{"date":"2024-04-26","current":11.622713,"twenty":-43.835622,"median":-28.43912,"eighty":-15.200526,"marketCap":4134861432},{"date":"2024-05-03","current":9.294065,"twenty":-43.835622,"median":-28.43912,"eighty":-15.01869,"marketCap":4037620480},{"date":"2024-05-10","current":9.449875,"twenty":-43.835622,"median":-28.43912,"eighty":-14.970096,"marketCap":4105309004},{"date":"2024-05-17","current":9.52778,"twenty":-43.835622,"median":-28.43912,"eighty":-14.582911,"marketCap":4139153267},{"date":"2024-05-24","current":9.348598,"twenty":-43.835622,"median":-28.43912,"eighty":-14.167324,"marketCap":4061311464},{"date":"2024-05-31","current":9.114883,"twenty":-43.835622,"median":-28.43912,"eighty":-13.940216,"marketCap":3959778677},{"date":"2024-06-07","current":9.313541,"twenty":-43.835622,"median":-28.43912,"eighty":-13.607896,"marketCap":4046081546},{"date":"2024-06-14","current":9.543361,"twenty":-43.835622,"median":-28.43912,"eighty":-13.123801,"marketCap":4145922119},{"date":"2024-06-21","current":9.718647,"twenty":-43.849732,"median":-28.439666,"eighty":-12.956146,"marketCap":4222071709},{"date":"2024-06-28","current":9.387551,"twenty":-43.849732,"median":-28.439666,"eighty":-12.533786,"marketCap":4078233595},{"date":"2024-07-05","current":9.46156,"twenty":-43.849732,"median":-28.439666,"eighty":-12.248451,"marketCap":4110385644},{"date":"2024-07-12","current":9.181102,"twenty":-43.849732,"median":-28.439666,"eighty":-11.555991,"marketCap":3988546300},{"date":"2024-07-19","current":9.671904,"twenty":-43.849732,"median":-28.439666,"eighty":-11.295982,"marketCap":4201765152},{"date":"2024-07-26","current":15.900891,"twenty":-43.849732,"median":-28.439666,"eighty":-10.747072,"marketCap":4590953012},{"date":"2024-08-02","current":15.809638,"twenty":-43.849732,"median":-28.439666,"eighty":9.065803,"marketCap":4564606079},{"date":"2024-08-09","current":14.868588,"twenty":-43.849732,"median":-28.439666,"eighty":9.206032,"marketCap":4292903337},{"date":"2024-08-16","current":15.541581,"twenty":-43.849732,"median":-28.439666,"eighty":9.350072,"marketCap":4487211965},{"date":"2024-08-23","current":15.940815,"twenty":-43.849732,"median":-28.439666,"eighty":9.384045,"marketCap":4602479795},{"date":"2024-08-30","current":16.225981,"twenty":-43.849732,"median":-28.439666,"eighty":9.410143,"marketCap":4684813960},{"date":"2024-09-06","current":15.319151,"twenty":-43.849732,"median":-28.439666,"eighty":9.422608,"marketCap":4422991316},{"date":"2024-09-13","current":15.775418,"twenty":-43.849732,"median":-28.439666,"eighty":9.46156,"marketCap":4554725980},{"date":"2024-09-20","current":16.283014,"twenty":-43.849732,"median":-28.439666,"eighty":9.509862,"marketCap":4701280792},{"date":"2024-09-27","current":15.701275,"twenty":-43.849732,"median":-28.439666,"eighty":9.56787,"marketCap":4533319097},{"date":"2024-10-04","current":16.522554,"twenty":-43.849732,"median":-28.439666,"eighty":9.600231,"marketCap":4770441491},{"date":"2024-10-11","current":16.488334,"twenty":-43.849732,"median":-28.439666,"eighty":9.670346,"marketCap":4760561391},{"date":"2024-10-18","current":16.123321,"twenty":-43.849732,"median":-28.439666,"eighty":9.754483,"marketCap":4655173660},{"date":"2024-10-25","current":12.663801,"twenty":-43.849732,"median":-28.439666,"eighty":11.422026,"marketCap":4221427433},{"date":"2024-11-01","current":12.848249,"twenty":-43.849732,"median":-28.439666,"eighty":11.702607,"marketCap":4282912386},{"date":"2024-11-08","current":14.008329,"twenty":-43.849732,"median":-28.439666,"eighty":12.289298,"marketCap":4669620380},{"date":"2024-11-15","current":13.683118,"twenty":-43.849732,"median":-28.439666,"eighty":12.552615,"marketCap":4561212700},{"date":"2024-11-22","current":13.969498,"twenty":-43.849732,"median":-28.439666,"eighty":12.712777,"marketCap":4656676180},{"date":"2024-11-29","current":14.085991,"twenty":-43.849732,"median":-28.439666,"eighty":12.812597,"marketCap":4695508782},{"date":"2024-12-06","current":15.27034,"twenty":-43.849732,"median":-28.439666,"eighty":12.900671,"marketCap":5090306901},{"date":"2024-12-13","current":14.809221,"twenty":-43.849732,"median":-28.439666,"eighty":13.110355,"marketCap":4936594519},{"date":"2024-12-20","current":14.42091,"twenty":-43.849732,"median":-28.439666,"eighty":13.442537,"marketCap":4807152512},{"date":"2024-12-27","current":14.343247,"twenty":-43.849732,"median":-28.439666,"eighty":13.559902,"marketCap":4781264111},{"date":"2025-01-03","current":14.095699,"twenty":-43.849732,"median":-28.439666,"eighty":13.693488,"marketCap":4698744832},{"date":"2025-01-10","current":13.629725,"twenty":-43.863842,"median":-28.440211,"eighty":13.770488,"marketCap":4543414424},{"date":"2025-01-17","current":14.304416,"twenty":-43.863842,"median":-28.440211,"eighty":13.833589,"marketCap":4768319910},{"date":"2025-01-24","current":15.139285,"twenty":-43.863842,"median":-28.440211,"eighty":13.948176,"marketCap":5046620224},{"date":"2025-01-31","current":15.304318,"twenty":-43.863842,"median":-28.440211,"eighty":13.976354,"marketCap":5101633077},{"date":"2025-02-07","current":15.323733,"twenty":-43.863842,"median":-28.440211,"eighty":14.085991,"marketCap":5108105177},{"date":"2025-02-14","current":15.899471,"twenty":-43.863842,"median":-28.440211,"eighty":14.192777,"marketCap":5836218864},{"date":"2025-02-21","current":15.646958,"twenty":-43.863842,"median":-28.440211,"eighty":14.231608,"marketCap":5743528846},{"date":"2025-02-28","current":15.208382,"twenty":-43.863842,"median":-28.440211,"eighty":14.30927,"marketCap":5582540920},{"date":"2025-03-07","current":15.217242,"twenty":-43.873027,"median":-28.454574,"eighty":14.44615,"marketCap":5585793201},{"date":"2025-03-14","current":15.075481,"twenty":-43.873027,"median":-28.454574,"eighty":14.62089,"marketCap":5533756700},{"date":"2025-03-21","current":15.327994,"twenty":-43.873027,"median":-28.454574,"eighty":14.815514,"marketCap":5626446718},{"date":"2025-03-28","current":14.913262,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5474211098},{"date":"2025-04-04","current":13.498725,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4954976983},{"date":"2025-04-11","current":12.124603,"twenty":-43.863842,"median":-28.440211,"eighty":14.886883,"marketCap":4450578129},{"date":"2025-04-17","current":12.124603,"twenty":-43.863842,"median":-28.440211,"eighty":14.886883,"marketCap":4450578129},{"date":"2025-04-25","current":12.501813,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4589040559},{"date":"2025-05-02","current":14.858162,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5240562837},{"date":"2025-05-09","current":14.086734,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4968475717},{"date":"2025-05-16","current":14.68985,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5181198374},{"date":"2025-05-23","current":14.049332,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4955283614},{"date":"2025-05-30","current":14.142838,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4988263871},{"date":"2025-06-06","current":14.493487,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5111939835},{"date":"2025-06-13","current":14.39063,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5075661552},{"date":"2025-06-20","current":13.712709,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4836554689},{"date":"2025-06-27","current":13.478943,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4754104046},{"date":"2025-07-03","current":13.488294,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4757402072},{"date":"2025-07-11","current":14.24102,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":5022893141},{"date":"2025-07-18","current":13.726735,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4841501727},{"date":"2025-07-25","current":12.40362,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4374831091},{"date":"2025-08-01","current":12.549766,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4372915663},{"date":"2025-08-08","current":12.59951,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4390248851},{"date":"2025-08-15","current":13.388312,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4665103686},{"date":"2025-08-22","current":13.767316,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4797166069},{"date":"2025-08-29","current":13.705728,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4775705932},{"date":"2025-09-05","current":13.70099,"twenty":-43.891396,"median":-28.472159,"eighty":14.891062,"marketCap":4774055152},{"date":"2025-09-12","current":13.127747,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4574310798},{"date":"2025-09-19","current":13.525701,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4712976300},{"date":"2025-09-26","current":12.852969,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4478565570},{"date":"2025-10-03","current":14.809576,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":5160337623},{"date":"2025-10-10","current":14.866427,"twenty":-43.882212,"median":-28.468938,"eighty":14.901614,"marketCap":5180146981},{"date":"2025-10-17","current":14.591649,"twenty":-43.882212,"median":-28.468938,"eighty":14.926634,"marketCap":5084401753},{"date":"2025-10-24","current":14.231595,"twenty":-43.882212,"median":-28.468938,"eighty":14.926634,"marketCap":4958942489},{"date":"2025-10-31","current":15.019277,"twenty":-43.882212,"median":-28.43912,"eighty":15.006893,"marketCap":5088921627},{"date":"2025-11-07","current":15.438375,"twenty":-43.882212,"median":-28.345638,"eighty":15.018474,"marketCap":5230922685},{"date":"2025-11-14","current":15.111868,"twenty":-43.882212,"median":-28.24177,"eighty":15.075763,"marketCap":5120293954},{"date":"2025-11-21","current":13.737619,"twenty":-43.882212,"median":-28.181663,"eighty":15.075763,"marketCap":4654662578},{"date":"2025-11-28","current":14.414997,"twenty":-43.882212,"median":-28.038026,"eighty":15.075763,"marketCap":4884175916},{"date":"2025-12-05","current":14.278547,"twenty":-43.882212,"median":-27.899005,"eighty":15.075763,"marketCap":4837943013},{"date":"2025-12-12","current":14.215195,"twenty":-43.674768,"median":-27.712042,"eighty":15.075763,"marketCap":4816477737},{"date":"2025-12-19","current":13.552437,"twenty":-43.352661,"median":-27.649721,"eighty":15.075763,"marketCap":4591917925},{"date":"2025-12-26","current":13.898436,"twenty":-43.181925,"median":-27.578386,"eighty":15.075763,"marketCap":4709151356},{"date":"2026-01-02","current":13.635282,"twenty":-42.896368,"median":-27.514693,"eighty":15.075763,"marketCap":4619987901},{"date":"2026-01-09","current":14.424744,"twenty":-42.786484,"median":-27.36293,"eighty":15.075763,"marketCap":4887478266},{"date":"2026-01-16","current":15.214206,"twenty":-42.614728,"median":-26.975109,"eighty":15.077555,"marketCap":5154968630},{"date":"2026-01-23","current":16.544596,"twenty":-42.460696,"median":-26.774017,"eighty":15.108565,"marketCap":5605739430},{"date":"2026-01-30","current":16.997806,"twenty":-42.298396,"median":9.072035,"eighty":15.139285,"marketCap":5759298713},{"date":"2026-02-06","current":16.349667,"twenty":-42.121898,"median":9.212264,"eighty":15.161285,"marketCap":5539692426},{"date":"2026-02-13","current":16.222964,"twenty":-41.959732,"median":9.350441,"eighty":15.201872,"marketCap":5496761874},{"date":"2026-02-20","current":15.594318,"twenty":-41.959732,"median":9.370022,"eighty":15.220786,"marketCap":5283760288},{"date":"2026-02-27","current":21.19121,"twenty":-41.959732,"median":9.407027,"eighty":15.261496,"marketCap":5121152471},{"date":"2026-03-06","current":19.549977,"twenty":-41.959732,"median":9.422608,"eighty":15.297588,"marketCap":4724525628},{"date":"2026-03-13","current":19.060366,"twenty":-41.959732,"median":9.46156,"eighty":15.319151,"marketCap":4606204175},{"date":"2026-03-20","current":19.584457,"twenty":-41.959732,"median":9.512199,"eighty":15.336854,"marketCap":4732858125},{"date":"2026-03-27","current":20.632639,"twenty":-41.959732,"median":9.570627,"eighty":15.412902,"marketCap":4986166025},{"date":"2026-04-02","current":24.112643,"twenty":-41.959732,"median":9.593999,"eighty":15.466036,"marketCap":5827157765},{"date":"2026-04-10","current":24.02321,"twenty":-41.959732,"median":9.664113,"eighty":15.524453,"marketCap":5805544912},{"date":"2026-04-17","current":23.228627,"twenty":-41.959732,"median":9.742018,"eighty":15.606447,"marketCap":5613523023},{"date":"2026-04-24","current":23.32838,"twenty":-41.959732,"median":11.418222,"eighty":15.661134,"marketCap":5637629667},{"date":"2026-05-01","current":23.19079,"twenty":-41.959732,"median":11.622713,"eighty":15.730243,"marketCap":5604379123},{"date":"2026-05-08","current":38.634911,"twenty":-41.959732,"median":11.940489,"eighty":15.814201,"marketCap":5900323567},{"date":"2026-05-15","current":41.8654,"twenty":-41.959732,"median":12.174,"eighty":15.879905,"marketCap":6393683956},{"date":"2026-05-22","current":40.326552,"twenty":-41.959732,"median":12.331299,"eighty":15.906771,"marketCap":6158671068},{"date":"2026-05-29","current":43.589783,"twenty":-41.964268,"median":12.423564,"eighty":15.957458,"marketCap":6657031731},{"date":"2026-06-05","current":47.344136,"twenty":-41.959732,"median":12.501813,"eighty":16.013817,"marketCap":7230396507},{"date":"2026-06-12","current":49.024864,"twenty":-41.898367,"median":12.572144,"eighty":16.034853,"marketCap":7487077250},{"date":"2026-06-18","current":48.577398,"twenty":-41.824976,"median":12.578191,"eighty":16.107352,"marketCap":7418740169},{"date":"2026-06-26","current":57.657693,"twenty":-41.817921,"median":12.645689,"eighty":16.158784,"marketCap":8805482883},{"date":"2026-07-02","current":56.446259,"twenty":-41.803329,"median":12.68891,"eighty":16.20592,"marketCap":8620472738},{"date":"2026-07-10","current":58.694506,"twenty":-41.535725,"median":12.773878,"eighty":16.314234,"marketCap":8963824900},{"date":"2026-07-17","current":56.686363,"twenty":-41.52535,"median":12.829717,"eighty":16.483549,"marketCap":8657141415},{"date":"2026-07-24","current":57.810486,"twenty":-41.508406,"median":12.912967,"eighty":16.53282,"marketCap":8828817496},{"date":"2026-07-31","current":126.933087,"twenty":-41.435384,"median":12.976145,"eighty":16.764866,"marketCap":8393196498},{"date":"2026-08-07","current":122.721435,"twenty":-41.179453,"median":13.089846,"eighty":17.012426,"marketCap":8114709466},{"date":"2026-08-14","current":125.461546,"twenty":-40.97486,"median":13.175122,"eighty":18.458256,"marketCap":8295893800},{"date":"2026-08-21","current":121.833436,"twenty":-40.812598,"median":13.242761,"eighty":18.732957,"marketCap":8055992321},{"date":"2026-08-28","current":124.066119,"twenty":-40.574229,"median":13.376086,"eighty":18.818872,"marketCap":8203624000},{"date":"2026-08-31","current":120.285781,"twenty":-40.55077,"median":13.388312,"eighty":18.83597,"marketCap":7953656725}],"updateTime":1788325074511},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALKS\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141547646","title":"Movement Alert｜Alkermes Rises 6.97% in Regular Trading, Narcolepsy Drug Phase 2 Trial Meets Dual Primary Endpoints and Advances to Phase 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1141547646","media":"Market Focus","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141547646?lang=en_us&edition=fundamental","pubTime":"2026-06-25 00:15","pubTimestamp":1782317759,"startTime":"0","endTime":"0","summary":"On June 25, Alkermes rose 6.97% in regular trading, trading at $51.395/share, with turnover of $82.54 million. The rally was driven by the company's announcement that its Phase 2 Vibrance-2 trial of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645828813","title":"Alkermes price target raised to $61 from $54 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2645828813","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645828813?lang=en_us&edition=fundamental","pubTime":"2026-06-24 20:35","pubTimestamp":1782304540,"startTime":"0","endTime":"0","summary":"Needham raised the firm’s price target on Alkermes (ALKS) to $61 from $54 and keeps a Buy rating on the shares. Published first on TheFly – the ult...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-price-target-raised-to-61-from-54-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-price-target-raised-to-61-from-54-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645897634","title":"Alkermes is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2645897634","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645897634?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:20","pubTimestamp":1782300000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings(END) Dow Jones NewswiresJune 24, 2026 07:20 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645891132","title":"Analysts Offer Insights on Healthcare Companies: McKesson (MCK) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645891132","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645891132?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:00","pubTimestamp":1782295226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on McKesson (MCK) and Alkermes (ALKS) with bullish sent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mckesson-mck-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mckesson-mck-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU0124676726.USD","LU0029874061.USD","LU0965509283.SGD","MCK","LU1061106388.HKD","BK4585","LU1983260115.SGD","LU0128526141.USD","LU1037948897.HKD","LU1023059063.AUD","BK4588","LU1934455863.HKD","LU1506573853.SGD","LU0114720955.EUR","HCSG","LU0742534661.SGD","XLV","LU0432979614.USD","LU0251142724.SGD","LU0203347892.USD","BK4139","BK4533","BK4581","LABU","LU1366192091.USD","LU0689626769.HKD","LU2468319806.SGD","BK4175","LU0122379950.USD","LU0203345920.USD","ALKS","BK4137","LU2324357040.USD","LU1430594728.SGD","LU0965509101.SGD","LU1057294990.SGD","LU0314106906.USD","LU2112291526.USD","LU0048573561.USD","LU1814569148.SGD","LU1934455277.USD","LU0868494708.USD","XBI","LU0942090050.USD","LU0965508806.USD","LU0965509010.AUD","LU1585245621.USD","LU0868494617.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645899662","title":"Alkermes Plc : Needham Raises Target Price to $61 from $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2645899662","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645899662?lang=en_us&edition=fundamental","pubTime":"2026-06-24 17:40","pubTimestamp":1782294048,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42W027:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029170","title":"Alkermes Plc : Deutsche Bank Raises Target Price to $60 From $47","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029170","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029170?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:04","pubTimestamp":1782126286,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42U02E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644370093","title":"Alkermes Plc : Needham Raises Target Price to $54 From $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2644370093","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644370093?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:08","pubTimestamp":1781780929,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0VI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644005157","title":"Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Alkermes (ALKS) and Connect Biopharma Holdings (CNTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644005157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644005157?lang=en_us&edition=fundamental","pubTime":"2026-06-18 18:51","pubTimestamp":1781779869,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Butterfly Network (BFLY), Alkermes (ALKS) and Connec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-alkermes-alks-and-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-alkermes-alks-and-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","LU0128526141.USD","LABU","BFLY","BK4588","XBI","BK4139","ALKS","BK4581","LU0029874061.USD","BK4585","BK4082","XLV","BK4137","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644707521","title":"Alkermes data support alixorexton in narcolepsy type 2, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2644707521","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644707521?lang=en_us&edition=fundamental","pubTime":"2026-06-18 18:31","pubTimestamp":1781778698,"startTime":"0","endTime":"0","summary":"H.C. Wainwright says Alkermes (ALKS)’ detailed results from the Vibrance-2 study provide additional insights into the broader effects of alixorexto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-data-support-alixorexton-in-narcolepsy-type-2-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-data-support-alixorexton-in-narcolepsy-type-2-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644704428","title":"Alkermes Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2644704428","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644704428?lang=en_us&edition=fundamental","pubTime":"2026-06-18 18:00","pubTimestamp":1781776800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 18, 2026 06:00 ET (10:00 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176433859","title":"Targeting the Brain's 'Wake Switch': Alkermes's Narcolepsy Drug Shows Promising Mid-Stage Data, Igniting Race in Orexin Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=1176433859","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176433859?lang=en_us&edition=fundamental","pubTime":"2026-06-18 14:06","pubTimestamp":1781762809,"startTime":"0","endTime":"0","summary":"Alkermes PLC announced on Wednesday at a major sleep medicine conference in Baltimore that its investigational drug alixorexton significantly improved the ability to stay awake and reduced excessive...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477","BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644210977","title":"Alkermes' Phase 2 Trial of Alixorexton to Treat Narcolepsy Meets Dual Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2644210977","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644210977?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:48","pubTimestamp":1781729303,"startTime":"0","endTime":"0","summary":"Alkermes  said late Wednesday that its phase 2 trial of alixorexton to treat narcolepsy type 2 met dual primary endpoints by demonstrating statistically significant improvements from baseline in mean sleep latency and excessive daytime sleepiness at week eight.Improvements in wakefulness were sustained through the five-week period, as the drug candidate also showcased clinically meaningful improvements across exploratory outcomes evaluating fatigue and cognition, the company said.Alixorexton was generally well tolerated, with no recorded serious treatment-emergent adverse events, according to a statement.The company has initiated a phase 3 trial of the drug, according to the company.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644721842","title":"Alkermes presents positive results from Phase 2 study of Alixorexton","url":"https://stock-news.laohu8.com/highlight/detail?id=2644721842","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644721842?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:20","pubTimestamp":1781727648,"startTime":"0","endTime":"0","summary":"Alkermes (ALKS) “announced detailed positive results from the Vibrance-2 phase 2 dose-ranging study evaluating alixorexton in patients with narcole...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-presents-positive-results-from-phase-2-study-of-alixorexton-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-presents-positive-results-from-phase-2-study-of-alixorexton-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644729743","title":"Alkermes says phase 2 Vibrance-2 trial shows alixorexton improves wakefulness in narcolepsy type 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2644729743","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644729743?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:15","pubTimestamp":1781727330,"startTime":"0","endTime":"0","summary":"Alkermes presented detailed Phase 2 Vibrance-2 results for alixorexton in narcolepsy type 2 at the SLEEP 2026 meeting.The once-daily orexin 2 receptor agonist improved wakefulness and reduced daytime sleepiness versus placebo, meeting both primary endpoints.Patient-reported fatigue and cognitive symptoms also improved, with benefits sustained during an open-label extension.The safety profile supported continued development, with no serious treatment-emergent adverse events reported.A global Phase 3 program has started in narcolepsy type 1 and type 2, testing once-daily and split-dose regimens.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via Business Wire  o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL9hp0rh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644729226","title":"Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at Sleep 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644729226","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644729226?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:15","pubTimestamp":1781727300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA4W1RL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643975947","title":"Alkermes (ALKS) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2643975947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643975947?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:56","pubTimestamp":1781607416,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst David Amsellem reiterated a Buy rating on Alkermes today and set a price target of $43.00. Amsellem covers the Healthcare sec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alkermes-alks-receives-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alkermes-alks-receives-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4139","LABU","BK4585","ALKS","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643620851","title":"Alkermes' Sleep Disorder Drug Receives Orphan Drug Status in US and Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2643620851","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643620851?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:32","pubTimestamp":1781523177,"startTime":"0","endTime":"0","summary":"Alkermes  said Monday that its experimental sleep disorder treatment, alixorexton, received orphan drug designation from US and European regulators.The company said the US Food and Drug Administration granted orphan status for the treatment of idiopathic hypersomnia, while the European Commission granted the designation for narcolepsy.Orphan drug designation helps provide regulatory and financial incentives, as well as market exclusivity for rare disease treatments if approved, it added.Alixorexton is currently being evaluated in phase 3 studies for narcolepsy type 1 and type 2 and a phase 2 study for idiopathic hypersomnia, Alkermes said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643270668","title":"Alkermes says alixorexton enters phase 3 Brilliance trials for narcolepsy type 1, type 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270668","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270668?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:04","pubTimestamp":1781521495,"startTime":"0","endTime":"0","summary":"Alkermes reported new orphan drug designations for alixorexton, its oral orexin 2 receptor agonist for sleep-wake disorders.Phase 2 results in narcolepsy type 1 and type 2 have already been presented, supporting plans to position the drug as a differentiated option.FDA granted orphan status for idiopathic hypersomnia; European Commission granted orphan status for narcolepsy, strengthening the program’s regulatory path.Phase 3 Brilliance studies in narcolepsy are enrolling; the phase 2 Vibrance-3 study in idiopathic hypersomnia is expected to complete this year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief on June 15, 2026, and is solely responsible for the i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL50qZjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643270598","title":"Alkermes says FDA grants orphan drug designation for alixorexton in idiopathic hypersomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270598","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270598?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:01","pubTimestamp":1781521302,"startTime":"0","endTime":"0","summary":"Alkermes won FDA orphan drug designation for alixorexton in idiopathic hypersomnia, strengthening its regulatory path in a rare sleep disorder.The European Commission granted orphan designation for alixorexton in narcolepsy, extending potential exclusivity incentives in the EU.The oral orexin 2 receptor agonist is in phase 3 studies for narcolepsy type 1 and type 2, with a phase 2 trial in idiopathic hypersomnia.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL6rCMk9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643270368","title":"Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270368","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270368?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA3RWRZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":4,"totalSize":171,"code":"91000000","status":"200"}]}}